Top compounds associated with response to GRB14


Feature Type Standardized
Nominal ANOVA
mRNA SB 505124 GDSC1000 pan-cancer AAC -0.017 0.7
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.018 0.7
mRNA BRD-K33199242 CTRPv2 pan-cancer AAC -0.018 0.7
mRNA GW843682X CTRPv2 pan-cancer AAC -0.016 0.7
mRNA Erlotinib UHNBreast pan-cancer AAC -0.13 0.7
mRNA Rapamycin CTRPv2 pan-cancer AAC 0.016 0.7
mRNA BMS-754807 GDSC1000 pan-cancer AAC 0.016 0.7
mRNA Methotrexate GDSC1000 pan-cancer AAC 0.014 0.7
mRNA Topotecan CTRPv2 pan-cancer AAC -0.015 0.7
mRNA Crizotinib gCSI pan-cancer AAC 0.027 0.7
Download CSV